Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.391,42
-0,78%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Spero Therapeutics Inc (SPRO) Spero Therapeutics Inc (SPRO) Notizie

Spero Therapeutics Inc

SPRO
1,65
0,04 (2,48%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/3/202414:05GLOBESpero Therapeutics to Provide Business Update and Report..
28/2/202414:05GLOBESpero Therapeutics Announces Clearance of IND for SPR206 to..
26/2/202414:05GLOBESpero Therapeutics to Present at Cowen’s 44th Annual..
09/2/202422:05EDGAR2Form 8-K - Current report
06/2/202402:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202402:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202422:50EDGAR2Form 144 - Report of proposed sale of securities
31/1/202422:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
08/1/202412:07EDGAR2Form 8-K - Current report
05/1/202414:11EDGAR2Form 8-K - Current report
05/1/202414:05GLOBESpero Therapeutics Provides Corporate Update and 2024..
04/1/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202414:13EDGAR2Form 8-K - Current report
02/1/202414:05GLOBESpero Therapeutics Announces First Patient, First Visit for..
15/11/202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202322:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/11/202322:50EDGAR2Form S-8 - Securities to be offered to employees in employee..
13/11/202322:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
13/11/202322:13EDGAR2Form 8-K - Current report
13/11/202322:05GLOBESpero Therapeutics Announces Third Quarter 2023 Operating..
13/11/202322:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202312:45IHMARKETNEWSMonday’s Wall Street Highlights: Boeing, Novo Nordisk,..
06/11/202314:05GLOBESpero Therapeutics to Provide Business Update and Report..
01/11/202321:05GLOBESpero Therapeutics to Present at Upcoming November Investor..
01/11/202313:10EDGAR2Form 8-K - Current report
01/11/202313:05GLOBESpero Therapeutics Appoints Esther Rajavelu as Chief..
31/10/202321:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
16/10/202322:01EDGAR2Form 8-K/A - Current report: [Amend]
10/10/202323:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202323:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202314:28EDGAR2Form 8-K - Current report
29/9/202322:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
20/9/202322:05GLOBESpero Therapeutics to Present at Cantor’s Global Healthcare..
15/9/202323:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202314:05GLOBESpero Therapeutics to Present at H.C. Wainwright 25th Annual..
01/9/202322:11EDGAR2Form ARS - Annual Report to Security Holders
01/9/202322:08EDGAR2Form DEF 14A - Other definitive proxy statements
31/8/202322:05GLOBESpero Therapeutics Announces Inducement Grants Under Nasdaq..
30/8/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202322:16EDGAR2Form 144 - Report of proposed sale of securities
22/8/202323:27EDGAR2Form PRE 14A - Other preliminary proxy statements
10/8/202322:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/8/202322:17EDGAR2Form 8-K - Current report
10/8/202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:05GLOBESpero Therapeutics Announces Second Quarter 2023 Operating..
Apertura: 1,63 Min: 1,62 Max: 1,6494
Chiusura: 1,61

La tua Cronologia

NASDAQ
SPRO
Spero Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network